je.st
news
Pharmaxis has a new business model - is it now the least risky biotech stock?
2015-09-21 09:47:29| Biotech - Topix.net
Pharmaxis was still reeling from a shock rejection of its cystic fibrosis drug Bronchitol by US drug regulators when Gary Phillips took charge in March 2013. Amid a frantic search for cash, the former chief operating officer also had to make some tough decisions about the kind of Pharmaxis needed to be if it were to survive.
Tags: the
now
business
least
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||